ARRAYDX

USPTO USPTO 2006 ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark ARRAYDX was filed as Word mark on 05/26/2006 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE".

Trademark Details

Trademark form Word mark
File reference 78894535
Application date May 26, 2006

Trademark owner

3434 Live Oak Street, Suite 125
75234 Dallas
US

Trademark representatives

goods and services

42 Scientific research services for third parties, namely, immobilization of arrays of chemical compounds, modification of nucleic acids; scientific, technological research services, namely, product design services for third parties in the field of biotechnology and pharmaceuticals, namely development of new technology for others; product design and development of new technology for others in the fields of individual preventative programs, disease treatment based on gene array and protein expression and/or activity; pharmaceutical drug development, namely, evaluating clinical trial progress, drug monitoring an computer tracking of a patient's health progress; product development services for third parties in the biomedical, genomic, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; computer services, namely, providing data and databases featuring life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, namely, providing data and databases featuring life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology

ID: 1378894535